Aligos Therapeutics, Inc. (ALGS) vs HeartBeam, Inc. (BEAT)
A side-by-side comparison of Aligos Therapeutics, Inc. and HeartBeam, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALGS
Aligos Therapeutics, Inc.
$5.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
BEAT
HeartBeam, Inc.
$0.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALGS vs BEAT
growth of $100 · dividends reinvested · last 5yALGS -98.7% (-58.1%/yr)BEAT -86.1% (-32.6%/yr)BEAT compounded faster over this window
Log scale — wide-divergence pair
ALGS BEAT
ALGS vs BEAT: by the numbers
- •ALGS is the larger company ($33M vs $32M market cap).
- •Both run net losses; BEAT's is the smaller (0.00% vs -241.01% net margin).
Metrics side by side
Valuation
| Metric | ALGS | BEAT |
|---|---|---|
| P/S ratio | 1.06 | N/A |
| P/B ratio | 1.04 | 3.96 |
Profitability
| Metric | ALGS | BEAT |
|---|---|---|
| Gross margin | 57.46% | 0.00% |
| Operating margin | -4024.93% | 0.00% |
| Net margin | -241.01% | 0.00% |
| ROE | -238.24% | -248.21% |
| ROIC | -207.97% | -249.58% |
Growth (annualized)
| Metric | ALGS | BEAT |
|---|---|---|
| Revenue CAGR (5Y) | -15.85% | N/A |
| Total return CAGR (5Y) | -57.15% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.